ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms
NCT: NCT07627828 · RECRUITING
Brief Summary
This prospective multicenter randomized controlled trial will compare stent-related symptoms after placement of a ComfiJ ureteral stent versus a conventional double-J ureteral stent in adult patients undergoing unilateral ureteroscopy or retrograde intrarenal surgery for urinary stones when short-term postoperative ureteral stenting is clinically indicated. Eligible patients will be randomized intraoperatively after the operating surgeon confirms the need for postoperative stenting. The primary outcome will be the Ureteral Stent Symptom Questionnaire urinary symptoms domain score on postoperative day 14 before planned stent removal.
Frequently Asked Questions
What is ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms?
ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms is a clinical trial registered under NCT07627828. Current status: RECRUITING.
What is the status of NCT07627828?
The current status of NCT07627828 (ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms) is: RECRUITING.
When did ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms start?
ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms started on 2026-05-02.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.